Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells

Journal of Virology

Volumn 81, Issue 9, 2007, Pages 4766-4775

  MacArthur, Georgina J ^a,b   Wilson, A Douglas ^a   Birchall, Martin A ^a   Morgan, Andrew J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GRANULYSIN; GRANZYME B;

ARTICLE; BLAST CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL COMPARTMENTALIZATION; CELL GROWTH; CELL POLARITY; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EFFECTOR CELL; EPSTEIN BARR VIRUS; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LATENT VIRUS INFECTION; LYMPH FOLLICLE; LYMPHOBLASTOID CELL; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMORY CELL; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TARGET CELL; TH1 CELL; TONSIL; UMBILICAL CORD BLOOD; VIRUS CELL INTERACTION;

B-LYMPHOCYTES; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; EPSTEIN-BARR VIRUS INFECTIONS; FETAL BLOOD; FLOW CYTOMETRY; HERPESVIRUS 4, HUMAN; HUMANS; MICROSCOPY, FLUORESCENCE; T-LYMPHOCYTES, HELPER-INDUCER; TONSIL;

HUMAN HERPESVIRUS 4;

EID: 34247612293     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02608-06     Document Type: Article

References (59)

1. Babcock, G. J., L. L. Decker, R. B. Freeman, and D. A. Thorley-Lawson. 1999. Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J. Exp. Med. 190:567-576.
2. Babcock, G. J., D. Hochberg, and A. D. Thorley-Lawson. 2000. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13:497-506.
3. Babcock, G. J., and D. A. Thorley-Lawson. 2000. Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. Proc. Natl. Acad. Sci. USA 97:12250-12255.
4. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
5. Bickham, K., and C. Munz. 2003. Contrasting roles of dendritic cells and B cells in the immune control of Epstein-Barr virus. Curr. Top. Microbiol. Immunol. 276:55-76.
6. Bickham, K., C. Munz, M. L. Tsang, M. Larsson, J. F. Fonteneau, N. Bhardwaj, and R. Steinman. 2001. EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function. J. Clin. Investig. 107:121-130.
7. Callan, M. F., C. Fazou, H. Yang, T. Rostron, K. Poon, C. Hatton, and A. J. McMichael. 2000. CD8(+) T-cell selection, function, and death in the primary immune response in vivo. J. Clin. Investig. 106:1251-1261.
8. Callan, M. F., N. Steven, P. Krausa, J. D. Wilson, P. A. Moss, G. M. Gillespie, J. I. Bell, A. B. Rickinson, and A. J. McMichael. 1996. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat. Med. 2:906-911.
9. Cheng, W. M., K. H. Chan, H. L. Chen, R. X. Luo, S. P. Ng, W. Luk, B. J. Zheng, M. F. Ji, J. S. Liang, J. S. Sham, D. K. Wang, Y. S. Zong, and M. H. Ng. 2002. Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum. Int. J. Cancer 97:489-492.
10. Cope, A. P., R. S. Liblau, X. D. Yang, M. Congia, C. Laudanna, R. D. Schreiber, L. Probert, G. Kollias, and H. O. McDevitt. 1997. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J. Exp. Med. 185:1573-1584.
11. Crawford, D. H., and I. Ando. 1986. EB virus induction is associated with B-cell maturation. Immunology 59:405-409.
12. de-Thé, G., A. Geser, N. E. Day, P. M. Tukei, E. H. Williams, D. P. Beri, P. G. Smith, A. G. Dean, G. W. Bronkamm, P. Feorino, and W. Henle. 1978. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 274:756-761.
13. + T-cell response to Epstein-Barr virus: T-cell-mediated activation of resting B cells and induction of viral BZLF1 expression. J. Virol. 74:6675-6679.
14. Gottschalk, S., C. M. Rooney, and H. E. Heslop. 2005. Post-transplant lymphoproliferative disorders. Annu. Rev. Med. 56:29-44.
15. He, B., N. Raab-Traub, P. Casali, and A. Cerutti. 2003. EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching. J. Immunol. 171:5215-5224.
16. Hill, A. B., S. P. Lee, J. S. Haurum, N. Murray, Q. Y. Yao, M. Rowe, N. Signoret, A. B. Rickinson, and A. J. McMichael. 1995. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised. J. Exp. Med. 181:2221-2228.
17. Hislop, A. D., M. Kuo, A. B. Drake-Lee, A. N. Akbar, W. Bergler, N. Hammerschmitt, N. Khan, U. Palendira, A. M. Leese, J. M. Timms, A. I. Bell, C. D. Buckley, and A. B. Rickinson. 2005. Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance. J. Clin. Investig. 115:2546-2555.
18. Hjalgrim, H., J. Askling, K. Rostgaard, S. Hamilton-Dutoit, M. Frisch, J. S. Zhang, M. Madsen, N. Rosdahl, H. B. Konradsen, H. H. Storm, and M. Melbye. 2003. Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N. Engl. J. Med. 349:1324-1332.
19. Imadome, K., M. Shirakata, N. Shimizu, S. Nonoyama, and Y. Yamanashi. 2003. CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation. Proc. Natl. Acad. Sci. USA 100:7836-7840.
20. Johannessen, I., M. Asghar, and D. H. Crawford. 2000. Essential role for T cells in human B-cell lymphoproliferative disease development in severe combined immunodeficient mice. Br. J. Haematol. 109:600-610.
21. Joseph, A. M., G. J. Babcock, and D. A. Thorley-Lawson. 2000. Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils. J. Virol. 74:9964-9971.
22. Keever-Taylor, C. A., B. Behn, S. Konings, R. Orentas, B. Davies, and D. Margolis. 2003. Suppression of EBV release from irradiated B lymphoblastoid cell-lines: superior activity of ganciclovir compared with acyclovir. Cytotherapy 5:323-335.
23. Khanolkar, A., Z. Fu, L. J. Underwood, K. L. Bondurant, R. Rochford, and M. J. Cannon. 2003. CD4(+) T cell-induced differentiation of EBV-transformed lymphoblastoid cells is associated with diminished recognition by EBV-specific CD8(+) cytotoxic T cells. J. Immunol. 170:3187-3194.
24. Khanolkar, A., H. Yagita, and M. J. Cannon. 2001. Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells. Virology 287:79-88.
25. Kis, L. L., M. Takahara, N. Nagy, G. Klein, and E. Klein. 2006. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1. Immunol. Lett. 104:83-88.
26. Kurth, J., M. L. Hansmann, K. Rajewsky, and R. Kuppers. 2003. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction. Proc. Natl. Acad. Sci. USA 100:4730-4735.
27. Laichalk, L. L., and D. A. Thorley-Lawson. 2005. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 79:1296-1307.
28. Lam, K. M., N. Syed, H. Whittle, and D. H. Crawford. 1991. Circulating Epstein-Barr virus-carrying B cells in acute malaria. Lancet 337:876-878.
29. Landais, E., X. Saulquin, E. Scotet, L. Trautmann, M. A. Peyrat, J. L. Yates, W. W. Kwok, M. Bonneville, and E. Houssaint. 2004. Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1. Blood 103:1408-1416.
30. Levine, P. H., G. Stemmermann, E. T. Lennette, A. Hildesheim, D. Shibata, and A. Nomura. 1995. Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma. Int. J. Cancer 60:642-644.
31. Levitskaya, J., M. Coram, V. Levitsky, S. Imreh, P. M. Steigerwald-Mullen, G. Klein, M. G. Kurilla, and M. G. Masucci. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685-688.
32. McHeyzer-Williams, L. J., and M. G. McHeyzer-Williams. 2005. Antigen-specific memory B cell development. Annu. Rev. Immunol. 23:487-513.
33. Münz, C., K. L. Bickham, M. Subklewe, M. L. Tsang, A. Chahroudi, M. G. Kurilla, D. Zhang, M. O'Donnell, and R. M. Steinman. 2000. Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. J. Exp. Med. 191:1649-1660.
34. Niederman, J. C., A. S. Evans, L. Subrahmanyan, and R. W. McCollum. 1970. Prevalence, incidence and persistence of EB virus antibody in young adults. N. Engl. J. Med. 282:361-365.
35. + T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation. J. Virol. 75:3740-3752.
36. +-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferation. J. Virol. 77:12088-12104.
37. + cytotoxic-T-lymphocyte killing of Epstein-Barr virus-infected cell lines. J. Virol. 77:4298-4305.
38. Perera, S. M., J. A. Thomas, M. Burke, and D. H. Crawford. 1998. Analysis of the T-cell micro-environment in Epstein-Barr virus-related post-transplantation B lymphoproliferative disease. J. Pathol. 184:177-184.
39. Piriou, E., K. van Dort, N. M. Nanlohy, M. H. van Oers, F. Miedema, and D. van Baarle. 2005. Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma. Blood 106:3166-3174.
40. Portis, T., and R. Longnecker. 2004. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway. Oncogene 23:8619-8628.
41. Prang, N. S., M. W. Hornef, M. Jager, H. J. Wagner, H. Wolf, and F. M. Schwarzmann. 1997. Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state. Blood 89:1665-1677.
42. Rennick, D. M., M. M. Fort, and N. J. Davidson. 1997. Studies with IL-10-/- mice: an overview. J. Leukoc. Biol. 61:389-396.
43. Rickinson, A. B., and E. Kieff. 2001. Epstein-Barr virus, p. 2575-2628. In P. M. Howley and D. M. Knipe (ed.), Fields virology, 4th ed., vol. 2. Lippincott Williams & Wilkins, Philadelphia, PA.
44. Rickinson, A. B., and D. J. Moss. 1997. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15:405-431.
45. Robinson, J., D. Smith, and J. Niederman. 1980. Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis. Nature 287:334-335.
46. Rochford, R., M. J. Cannon, R. E. Sabbe, K. Adusumilli, G. Picchio, J. M. Glynn, D. J. Noonan, D. E. Mosier, and M. V. Hobbs. 1997. Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell lines. Viral Immunol. 10:183-195.
47. Schaft, N., B. Lankiewicz, J. Drexhage, C. Berrevoets, D. J. Moss, V. Levitsky, M. Bonneville, S. P. Lee, A. J. McMichael, J. W. Gratama, R. L. Bolhuis, R. Willemsen, and R. Debets. 2006. T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNgamma production. Int. Immunol. 18:591-601.
48. Shi, Y., K. D. Smith, M. G. Kurilla, and C. T. Lutz. 1997. Cytotoxic CD8+ T cells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts: immunodominance is elicited by a peptide epitope that is presented at low levels in vitro. J. Immunol. 159:1844-1852.
49. Souza, T. A., B. D. Stollar, J. L. Sullivan, K. Luzuriaga, and D. A. Thorley-Lawson. 2005. Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells. Proc. Natl. Acad. Sci. USA 102:18093-18098.
50. Sun, Q., R. L. Burton, and K. G. Lucas. 2002. Cytokine production and cytolytic mechanism of CD4(+) cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures. Blood 99:3302-3309.
51. Thorley-Lawson, A. D. 2001. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1:75-82.
52. Thorley-Lawson, D. A., and A. Gross. 2004. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 350:1328-1337.
53. Vinuesa, C. G., S. G. Tangye, B. Moser, and C. R. Mackay. 2005. Follicular B helper T cells in antibody responses and autoimmunity. Nat. Rev. Immunol. 5:853-865.
54. Wang, S., and L. Chen. 2004. T lymphocyte co-signaling pathways of the B7-CD28 family. Cell. Mol. Immunol. 1:37-42.
55. Whitney, B. M., A. T. Chan, A. B. Rickinson, S. P. Lee, C. K. Lin, and P. J. Johnson. 2002. Frequency of Epstein-Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients. J. Med. Virol. 67:359-363.
56. Wilson, A. D., J. C. Hopkins, and A. J. Morgan. 2001. In vitro cytokine production and growth inhibition of lymphoblastoid cell lines by CD4+ T cells from Epstein-Barr virus (EBV) seropositive donors. Clin. Exp. Immunol. 126:101-110.
57. Wilson, A. D., and A. J. Morgan. 1998. Indirect measurement of Epstein-Barr virus neutralising antibodies by ELISA. J. Virol. Methods 73:11-19.
58. + T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro. J. Virol. 76:5071-5081.
59. Wilson, A. D., I. Redchenko, N. A. Williams, and A. J. Morgan. 1998. CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis. Int. Immunol. 10:1149-1157.